This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Stemsynergy Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dennis Liang Fei: Innovator in MYC Inhibitors
Introduction
Dennis Liang Fei is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of MYC inhibitors. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Dennis holds a patent titled "MYC INHIBITORS AND USES THEREOF." This patent represents his commitment to exploring new therapeutic avenues and addressing critical health challenges. With 1 patent to his name, he is making strides in the realm of cancer research and treatment.
Career Highlights
Dennis is currently employed at Stemsynergy Therapeutics, Inc., where he continues to push the boundaries of scientific research. His role at the company allows him to collaborate with other talented professionals in the field, contributing to groundbreaking advancements in therapeutic solutions.
Collaborations
Some of his coworkers include Samir Saleh and Thomas Doundoulakis. Their collective expertise fosters an environment of innovation and creativity, driving the mission of Stemsynergy Therapeutics forward.
Conclusion
Dennis Liang Fei is a dedicated inventor whose work in MYC inhibitors is paving the way for new treatments in biotechnology. His contributions are vital to the ongoing efforts in medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile